Rheumatoid arthritis (RA)
Paul Emery, MD, FRCP, MA, FMedSci
University of Leeds
Leeds, United Kingdom
Disclosure(s): Boehringer Ingelheim: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Novartis: Consultant (Ongoing)
Bryant England, MD, PhD, RhMSUS
University of Nebraska Medical Center
Omaha, NE, United States
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing)
This session will provide insights into clinical rheumatologic care and will help to predict where data will change practice over the coming year. This may include RA, SLE, seronegative arthritis, and other trends.
Speaker: Bryant England, MD, PhD, RhMSUS – University of Nebraska Medical Center
Speaker: Paul Emery, MD, FRCP, MA, FMedSci – University of Leeds